"Unraveling the Mechanism of Action: The Science Behind GLP-1 Drugs for Weight Loss"
GLP-1 analogues like semaglutide, initially used for type 2 diabetes, have gained attention for their ability to aid weight loss and reduce appetite. Research has shown that these drugs work by mimicking the action of a molecule released by the intestines after eating, affecting insulin release, gastric emptying, and sense of fullness. Studies also suggest potential benefits for minimizing the risk of cancer and cardiovascular disease. However, there is still uncertainty about the mechanisms behind these effects, and further research is needed to understand the long-term impact and potential side effects of these drugs.